OrbiMed Acquires Units of Response Biomedical Corporation
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/06/12 -- OrbiMed Advisors LLC ("OrbiMed"), a leading investment management firm focused on the healthcare sector, announces that it has acquired 67,024,129 units ("Units") of Response Biomedical Corporation ("Response Biomedical") as at December 30, 2011. The Units were acquired pursuant to a rights offering ("Rights Offering") by Response Biomedical. Each Unit consists of one common share ("Shares") and one common share purchase warrant ("Warrants"), with each Warrant exercisable for one additional Share ("Warrant Shares") at a price of $0.0746 per Warrant Share for a period of five years after the closing of the Rights Offering.
Response Biomedical is a Vancouver based company which develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP® Platform for clinical and environmental applications.
With the acquisition of the Units, OrbiMed entities OrbiMed Asia Partners, L.P., OrbiMed Private Investments III, LP and OrbiMed Associates III, LP hold in the aggregate 81,585,629 Shares representing an aggregate total of approximately 63.2% of the issued and outstanding Shares of Response Biomedical. In addition, the OrbiMed entities hold in the aggregate 67,024,129 Warrants exercisable for up to 67,024,129 Warrant Shares.
The Units were acquired for investment purposes, and the OrbiMed entities may acquire further securities, or dispose of their holdings of securities, both as investment conditions warrant.
OrbiMed presently has its head office at 767 Third Avenue, 30th Floor, New York, NY 10017. Beginning on January 9, its head office will be located at 601 Lexington Avenue, 54th Floor, New York, NY 10022. For further information, including a copy of the early warning report, please contact Alex Cooper at (212) 739-6400.
Contacts:
OrbiMed
Alex Cooper
(212) 739-6400
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.01.2012 - 13:49 Uhr
Sprache: Deutsch
News-ID 1070641
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
VANCOUVER, BRITISH COLUMBIA
Phone:
Kategorie:
Alternative
Anmerkungen:
Diese Pressemitteilung wurde bisher 210 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"OrbiMed Acquires Units of Response Biomedical Corporation
"
steht unter der journalistisch-redaktionellen Verantwortung von
OrbiMed (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
